Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Shanghai Huaota Biopharmaceutical Co., Ltd.
Enrollment target
~33 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated February 2025